Could a new pill calm brain inflammation and slow Parkinson's-Linked sleep disorder?
Disease control
Ongoing
This study tests whether an oral drug called PXS-4728A can reduce brain inflammation in 40 adults aged 50-80 with isolated REM sleep behavior disorder (iRBD), a condition often leading to Parkinson's disease. Participants receive either the drug or a placebo for 12 weeks, and bra…
Phase: PHASE2 • Sponsor: Syntara • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC